• Phone : +82 – 02 - 2228 - 1545 / 1541
• Fax : +82 – 02 - 365-5118
• E-mail : healthpro@yuhs.ac
• Address : National Health Promotion Research Institute, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea

This study aims to identify the factors of disease occurrence and changes in medical expenditure through a retrospective cohort established based on health examination data as of 1992, and to provide basic data necessary for disease management and policy direction establishment at the national level.

Intractable metabolic syndrome research, which has been conducted since 2005, aims to develop a Korean-specific metabolic syndrome prevention and management method by establishing a large-scale cohort of metabolic syndrome of Koreans and long-term tracking. It is intended to prospectively track the occurrence of diseases and to identify the environmental and genetic causes of chronic diseases.

From 2015 to 2018, with the support of the Korea Food and Drug Administration, establish a cohort research base for the regulation of tobacco product ingredients and emissions for the implementation of Articles 9 and 10 of the FCTC, develop tobacco product ingredients and emissions, and secure domestic data. By doing so, it was intended to support the policy for the management of harmful substances in tobacco products and emissions.

From 2015 to 2017, with the support of the Korea Food and Drug Administration, we attempted to establish a precautionary system through integrated risk management from the perspective of environmental hormones and other effects.

From 2014 to 2019, with the support of the National Health Industry Promotion Agency, by discovering predictive indicators for the occurrence of metabolic syndrome and complications of diabetes (heart disease, fatty liver disease, colorectal cancer), and by finding and managing high-risk groups in advance, it reduces unmet medical demand and prevents the public. I wanted to reduce medical expenses.